What's new?

Latest News

Keep up with the latest news from Research breakthroughs to Company news

Stay Connected

Explore Our Latest Insights on LinkedIn

News

Find All the Current News Here as We Continue Our Journey in Advancing Bacteriophage Solutions

From Classroom to Lab: Student Interns Reflect on Their Experience at Proteon Pharmaceuticals
20Sep

At Proteon Pharmaceuticals S.A., we’re dedicated to supporting the growth of future scientists and professionals. This summer, we offered the internships to six students, eager…

Proteon Pharmaceuticals Receives European Patent for Innovative Poultry Diagnostic Method
20Jun

Proteon Pharmaceuticals is thrilled to announce the obtaining of a new European patent for our pioneering technology: “Method and Kit for Detection of Extraintestinal E.…

Introducing „Inside Innovation: Micro Talks with the CEO” – A Social Media Video Series
03Jun

We are excited to introduce our new video series “Inside Innovation: Micro Talks with the CEO”, launching today on our social media channels. In this…

Innovations in Mastitis Diagnosis: Tackling Pathogen Detection Obstacles by Proteon Pharmaceuticals
24May

Proteon Pharmaceuticals is glad to announce the latest findings from our recent studies: “A Rapid and Inexpensive PCR Test for Mastitis Diagnosis Based on NGS…

Detecting Bacteria and Tackling Antibiotic Resistance: Proteon Pharmaceuticals Shares the Latest Outcomes
14May

Our dedicated Research and Development Team is thrilled to announce the results of one of the recently conducted breakthrough studies: “Novel multiplex-PCR test for Escherichia…

Executive Forecast: “Poland 2023: Roadmap to Sustainable Healthcare” Edition – an interview with Jarosław Dastych, the CEO and founder of Proteon Pharmaceuticals
15Apr

In the recent report prepared by the Executive Forecast, Professor Jarosław Dastych shared his passion for bacteriophage technology and threw light upon how it can…

Proteon Pharmaceuticals Opens a New Modern Production Facility in India
20Mar

Proteon Pharmaceuticals S.A. is pleased to announce the launch of their latest manufacturing facility in India. This 700-metre square factory is designed with cutting-edge zones…

Márcio Caparroz Joins Proteon Pharmaceuticals as Chief Commercial Officer
04Mar

Proteon Pharmaceuticals S.A. is delighted to announce the appointment of Márcio Caparroz as our new Chief Commercial Officer (CCO), starting 1st March 2024. Márcio brings…

Proteon Pharmaceuticals S.A.: the year 2023 at a glance
17Jan

Now as 2024 unfolds, let’s take a moment to reflect on the key events and milestones of 2023 with a comprehensive summary.    In the…

Unveiling the Advancements in Phage Technology: A Quantum Leap in Understanding for Enhanced Animal Production Benefits
07Dec

In the year’s closing interview with Feedinfo, Justyna Andrysiak, Chief Product and Technology Officer at Proteon Pharmaceuticals, sheds light on the recent breakthroughs and the…

Proteon Pharmaceuticals: Pioneering Bacteriophage Technology for Global Health Challenges
14Oct

In an exclusive interview with Hind Poultry, Professor Jarosław Dastych, the Founder and CEO of Proteon Pharmaceuticals, shares the company’s pioneering work in the field…

Proteon Pharmaceuticals: Pioneering Bacteriophage Technology for Global Health Challenges
27Sep

In a recent interview with The Poultry Site, Professor Jarosław Dastych, the Founder and CEO of Proteon Pharmaceuticals, shared insights into the company’s pioneering efforts…

Proteon Pharmaceuticals Accelerates Innovation with the Inauguration of the Center for Bacteriophage Biotechnology (CBB)
05Sep

In an interview conducted by the Feedinfo with DrEwelina Wójcik, Chief Scientific Officer at Proteon Pharmaceuticals, the latter outlined the core mission of the CBB…

<strong>Advancing Bacteriophage Research:  Proteon Pharmaceuticals opens the Center for Bacteriophage Biotechnology in Łódź</strong>
21Jul

Łódź, 21 July 2023 – Proteon Pharmaceuticals opens the Center for Bacteriophage Biotechnology in Łódź Proteon Pharmaceuticals is delighted to announce the inauguration of its groundbreaking…

Proteon Pharmaceuticals Spearheads Sustainable Agricultural Solutions to Curb Antibiotic Use
18Aug

Proteon Pharmaceuticals was featured by CBS News under the Global Thought Leaders campaign, highlighting innovation at its core through biotechnology and dedication to improving animal…

<strong>Janusz Wojciechowski, EU Commissioner for Agriculture, visited Proteon Pharmaceuticals.</strong>
09May

Łódź, 9 May 2022 – Janusz Wojciechowski, EU Commissioner for Agriculture, visited Proteon Pharmaceuticals today. Commissioner Wojciechowski’s visit to Proteon Pharmaceuticals is to get better acquainted…

Proteon Pharmaceuticals Secures 21 million Euro to Accelerate Growth
10Aug

Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within…

EFSA confirms safety of BAFASAL®, A “First in Class”, innovative feed additive
17May

PROTEON CONTINUES DIALOGUE WITH EU COMMISSION TO SECURE EARLY AUTHORIZATION In its first-ever evaluation of a bacteriophage feed additive, EFSA (European Food Safety Authority) concluded…

Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture
27Jan

Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition
09Sep

The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish…

Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses
27May

In 2008, a superbug caught from a New Delhi hospital claimed the life of a Swedish patient. British scientists who found this “superbug” in New…

Proteon Pharmaceuticals Joins Research Efforts to Fight Coronavirus
24Mar

In response to the fight against coronavirus, Proteon Pharmaceuticals has joined the effort to create a new SARS-CoV-2 Coronavirus Detection Center in Lodz, Poland to…

Proteon receives European grant to fight bacterial infections in fish farming, otherwise known as aquaculture farming.
21Aug

A Łódź pharmaceutical company has received over 2 million Euros to reduce animal antibiotics in the human food chain. In an attempt to find a…

Proteon Joins The U.S. Poultry & Egg Association
26Jul

Proteon Pharamceuticals, a global leader in the development and commercialization of bacteriophages for industrial use in poultry farming, is now a member of the U.S.…

Proteon Pharmaceuticals Awarded 2,9 mln Euro Grant for the Development of Bacteriophage Aquaculture Product
25Jul

Polish biotech company Proteon Pharmaceuticals S.A, a global leader in the development and commercialization of bacteriophages for industrial use in livestock farming in poultry, dairy…

Proteon receives the “Best Innovation in Aquaculture Award” at the Global Forum for Innovations in Agriculture (GFIA)
08Apr

Proteon received the Best “Innovation in Aquaculture Award”, from His Excellency, Saeed Albahri Salem Alameri, and Hans van der Beek, Director General of the Abu…

Proteon Founder, Professor Jarosław Dastych, presents on “Aquaculture: Challenges and Lessons of Product Development” at the Bacteriophage Therapy Summit, Boston, USA.
08Apr

Proteon Founder and Board Member, Professor Jarosław Dastych, made a major presentation at the Bacteriophage Therapy Summit in Boston, USA. He spoke on the topic…

Proteon Receives “2019 Animal Health Innovation Award” at the Animal Health Investment Europe Conference
08Apr

Proteon Receives “2019 Animal Health Innovation Award” at the Animal Health Investment Europe Conference in London, UK.. COO and Board Member Matthew Tebeau accepted the…

Proteon Pharmaceuticals is Fighting Salmonella by Attacking it on the Farm
24Jan

Proteon Pharmaceuticals COO Matthew Tebeau sat down with Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco. The Poland-based biotech…

Proteon Pharmaceuticals gives an extensive comment on Salmonella issue in Poland in a video interview for a Polish business wire agency
17Jul

Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within…

Proteon Pharmaceuticals was invited to present its bacteriophage technology at the prestigious animal nutrition conference FIAAP in Bangkok
16May

Proteon Pharmaceuticals was an invited speaker at the 9th edition of the FIAAP Animal Nutrition conference held on March 27, 2018 in Bangkok, Thailand. This…

Proteon Pharmaceuticals attracts environmental impact investment fund
24Oct

Proteon Pharmaceuticals S.A., a Polish biotechnology firm has signed an agreement with an international Investment Fund, the Aqua-Spark fund, which invests in sustainable aquaculture. Proteon…

BAFADOR® presented at the international bacteriophage conference in Tbilisi
03Jul

Proteon Pharmaceuticals presents its unique product BAFADOR® at the international bacteriophage conference in Tbilisi Proteon Pharmaceuticals participated in the international conference “Centennial Celebration of Bacteriophage…

Proteon Pharmaceuticals awarded grants for Euro 3.2 m
06Feb

In 2016 Proteon Pharmaceuticals awarded grants from Polish Center for Research & Development for Euro 3.2 m In 2016, Proteon Pharmaceuticals signed the agreements for…